Penumbra PEN - Options Chain | ADVFN

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NYSE
Penumbra Inc (PEN)
Penumbra Inc (PEN) Options

Penumbra Inc (PEN)

277.69

-8.69

(-3.03%)

Closed March 06 4:00PM

Delayed by 15 minutes

277.69

0.00

( 0.00% )

Pre Market: 5:13AM

Delayed by 15 minutes

PEN Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
190.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
195.00	81.00	85.90	0.00	83.45	0.00	0.00 %	0	0	-
200.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
210.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
220.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
230.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
240.00	37.00	40.60	0.00	38.80	0.00	0.00 %	0	0	-
250.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
260.00	19.00	22.60	44.20	20.80	0.00	0.00 %	0	2	-
270.00	12.40	15.30	20.40	13.85	0.00	0.00 %	0	7	-
280.00	6.60	8.70	13.00	7.65	0.00	0.00 %	0	160	-
290.00	2.95	5.20	7.90	4.075	0.00	0.00 %	0	2,524	-
300.00	1.10	3.30	2.20	2.20	-1.40	-38.89 %	2	729	3/06/2025
310.00	0.55	2.50	2.60	1.525	0.00	0.00 %	0	37	-
320.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
330.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
340.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
350.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
360.00	0.00	1.75	0.00	0.00	0.00	0.00 %	0	0	-
370.00	0.00	0.95	0.00	0.00	0.00	0.00 %	0	0	-

Professional-Grade Tools, for Individual Investors.

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
190.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
195.00	0.00	2.15	0.00	0.00	0.00	0.00 %	0	0	-
200.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
210.00	0.00	2.25	0.00	0.00	0.00	0.00 %	0	0	-
220.00	0.42	2.40	0.42	1.41	0.00	0.00 %	0	7	-
230.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
240.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
250.00	1.05	1.90	1.00	1.475	0.00	0.00 %	0	6	-
260.00	1.50	4.40	2.00	2.95	0.00	0.00 %	0	11	-
270.00	4.30	6.00	5.50	5.15	0.00	0.00 %	0	25	-
280.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
290.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
300.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
310.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
320.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
330.00	50.50	54.50	0.00	52.50	0.00	0.00 %	0	0	-
340.00	60.00	64.80	0.00	62.40	0.00	0.00 %	0	0	-
350.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
360.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-
370.00	0.00	0.00	0.00	0.00	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SUNESUNation Energy Inc	$ 0.3354 (89.38%)	58.6M
HFBLHome Federal Bancorp Inc of Louisiana	$ 19.85 (53.88%)	5
BBGIBeasley Broadcast Group Inc	$ 9.99 (53.46%)	37
PSTVPlus Therapeutics Inc	$ 2.17 (50.69%)	10.47M
VTVTvTv Therapeutics Inc	$ 25.00 (49.88%)	4
SYRESpyre Therapeutics Inc	$ 13.01 (-36.54%)	19
LUNRIntuitive Machines Inc	$ 7.40 (-34.28%)	961.22k
PROVProvident Financial Holdings Inc	$ 11.20 (-24.78%)	17
USCBUSCB Financial Holdings Inc	$ 14.20 (-20.89%)	12
OMEROmeros Corporation	$ 5.95 (-20.40%)	4
SUNESUNation Energy Inc	$ 0.3354 (89.38%)	58.6M
FAMIFarmmi Inc	$ 0.3047 (33.29%)	32.23M
PSTVPlus Therapeutics Inc	$ 2.17 (50.69%)	10.47M
CTMXCytomX Therapeutics Inc	$ 0.90 (45.80%)	7.81M
PEVPhoenix Motor Inc	$ 0.4108 (20.79%)	5.55M

@LaughinPaulRyan

@LaughinPaulRyan 4 years ago

... ALL NEWS IS GOOD? ... $PEN

CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

@LaughinPaulRyan

@LaughinPaulRyan 4 years ago

QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
Situation constitutes existential threat to Penumbra’s viability as a public company

@LaughinPaulRyan

@LaughinPaulRyan 4 years ago

Executive Summary

Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients

davidsson10

davidsson10 4 years ago

https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link

@LaughinPaulRyan

@LaughinPaulRyan 4 years ago

... ROFLMFAO ... $PEN

Penumbra Inc
Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
CURRENT PRICE

PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020

TREND1

TREND1 10 years ago

IPO INFO

http://www.marketwatch.com/tools/ipo-calendar

TREND1

TREND1 10 years ago

IPO NOW HAS SYMBOL
Penumbra PEN

TREND1

TREND1 10 years ago

IPO should be out soon.
no symbol yet.

Aura Renewable Acquisiti...

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions